INmune Bio Email Formats

Biotechnology Research • Boca Raton, Florida, United States • 11-20 Employees

INmune Bio Email Formats

INmune Bio uses 3 email formats. The most common is {first initial}{last name} (e.g., jdoe@inmunebio.com), used 84.6% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@inmunebio.com	84.6%
{first name}{last name}	johndoe@inmunebio.com	7.7%
{last name}{last name}	doedoe@inmunebio.com	7.7%

Key Contacts at INmune Bio

Ed Baracchini

Member Board Of Directors

Rj Tesi

Ceo And Cmo

Scott Juda

Member Board Of Directors/Chairman Of Audit Commitee

Therese Blomberg

Director, Clinical Research Science

Company overview

Headquarters	255 NE Mizner B, Suite 640, Boca Raton, Florida 33432, US
Phone number	+15617100512
Website	inmunebio.com
NAICS	541714
SIC	873
Employees	11-20
Socials

About INmune Bio

INmune Bio Inc. is a clinical stage immuno-oncology company focused on harnessing the patient’s immune system to treat cancer. INKmune, the company’s lead product, primes patient’s NK cells (natural killer cells) to kill cancer. INmune is targeting residual disease, the cancer cells that survive initial treatments that return to cause the cancer relapse. By controlling residual disease, patients may live longer. Using a novel mechanism of action and a precision medicine approach, INKmune therapy should enhance NK cells’ ability to eliminate residual disease. Media coverage provided for informational purposes only and third party links provided as a resource. INmune Bio does not control the content of third parties. XPro1595, Quellor, LIVNate, INB03, INKmune and other drug candidates, have not yet been shown to be safe or effective, and has not been approved by any regulatory body.